Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Product Type
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
KI-696 is an inhibitor of the protein-protein interaction between Kelch-like ECH-associated protein 1 (Keap1) and nuclear factor erythroid 2-related factor 2 (Nrf2).1 It binds to the Keap1 Kelch domain (Kd = 1.3 nM) and increases the accumulation of Nrf2 in isolated human bronchial epithelial cells in a concentration-dependent manner. KI-696 increases the expression of the Nrf2 target genes NQO1, GCLM, HMOX1, and TXNRD1 in bronchial epithelial cells isolated from patients with chronic obstructive pulmonary disease (COPD; EC50s = 22, 36, 16, and 27 nM, respectively). In vivo, KI-696 (50 µmol/kg) increases lung expression of Nqo1, Hmox1, and Txnrd1 in rats.
WARNING This product is not for human or veterinary use.
1. Monoacidic inhibitors of the Kelch-